Patents by Inventor Patrick T. MOONEY

Patrick T. MOONEY has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Enantiomerically purified GPER agonist for use in treating disease states and conditions
    Patent number: 11760749
    Abstract: The present disclosure provides 1) an enantiomerically purified compound SRR G-1, or a derivative thereof, including specific crystal forms, salts and co-crystals that modulates G protein-coupled estrogen receptor activity, 2) pharmaceutical and cosmetic compositions comprising an enantiomerically purified SRR G-1, or a derivative thereof, and 3) methods of treating or preventing disease states and conditions and cosmetic conditions mediated through these receptors and related methods thereof in humans and animals.
    Type: Grant
    Filed: February 25, 2021
    Date of Patent: September 19, 2023
    Assignee: Linnaeus Therapeutics, Inc.
    Inventors: Christopher Natale, Patrick T. Mooney, Tina Garyantes, Wayne Luke
  • ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS
    Publication number: 20220089576
    Abstract: The present disclosure provides 1) an enantiomerically purified compound SRR G-1, or a derivative thereof, including specific crystal forms, salts and co-crystals that modulates G protein-coupled estrogen receptor activity, 2) pharmaceutical and cosmetic compositions comprising an enantiomerically purified SRR G-1, or a derivative thereof, and 3) methods of treating or preventing disease states and conditions and cosmetic conditions mediated through these receptors and related methods thereof in humans and animals.
    Type: Application
    Filed: May 24, 2021
    Publication date: March 24, 2022
    Inventors: Christopher NATALE, Patrick T. MOONEY, Tina GARYANTES, Wayne LUKE
  • ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS
    Publication number: 20220033385
    Abstract: The present disclosure provides 1) an enantiomerically purified compound SRR G-1, or a derivative thereof, including specific crystal forms, salts and co-crystals that modulates G protein-coupled estrogen receptor activity, 2) pharmaceutical and cosmetic compositions comprising an enantiomerically purified SRR G-1, or a derivative thereof, and 3) methods of treating or preventing disease states and conditions and cosmetic conditions mediated through these receptors and related methods thereof in humans and animals.
    Type: Application
    Filed: February 25, 2021
    Publication date: February 3, 2022
    Applicant: Linnaeus Therapeutics, Inc.
    Inventors: Christopher NATALE, Patrick T. MOONEY, Tina GARYANTES, Wayne LUKE
  • Enantiomerically purified GPER agonist for use in treating disease states and conditions
    Patent number: 10934277
    Abstract: The present disclosure provides 1) an enantiomerically purified compound SRR G-1, or a derivative thereof, including specific crystal forms, salts and co-crystals that modulates G protein-coupled estrogen receptor activity, 2) pharmaceutical and cosmetic compositions comprising an enantiomerically purified SRR G-1, or a derivative thereof, and 3) methods of treating or preventing disease states and conditions and cosmetic conditions mediated through these receptors and related methods thereof in humans and animals.
    Type: Grant
    Filed: November 13, 2019
    Date of Patent: March 2, 2021
    Assignee: LINNAEUS THERAPEUTICS, INC.
    Inventors: Christopher Natale, Patrick T. Mooney, Tina Garyantes, Wayne Luke
  • ENANTIOMERICALLY PURIFIED GPER AGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS
    Publication number: 20200140417
    Abstract: The present disclosure provides 1) an enantiomerically purified compound SRR G-1, or a derivative thereof, including specific crystal forms, salts and co-crystals that modulates G protein-coupled estrogen receptor activity, 2) pharmaceutical and cosmetic compositions comprising an enantiomerically purified SRR G-1, or a derivative thereof, and 3) methods of treating or preventing disease states and conditions and cosmetic conditions mediated through these receptors and related methods thereof in humans and animals.
    Type: Application
    Filed: November 13, 2019
    Publication date: May 7, 2020
    Applicant: Linnaeus Therapeutics, Inc.
    Inventors: Christopher NATALE, Patrick T. MOONEY, Tina GARYANTES, Wayne LUKE
  • ENANTIOMERICALLY PURIFIED GPER ANGONIST FOR USE IN TREATING DISEASE STATES AND CONDITIONS
    Publication number: 20200024262
    Abstract: The present disclosure provides 1) an enantiomerically purified compound SRR G-1, or a derivative thereof, including specific crystal forms, salts and co-crystals that modulates G protein-coupled estrogen receptor activity, 2) pharmaceutical and cosmetic compositions comprising an enantiomerically purified SRR G-1, or a derivative thereof, and 3) methods of treating or preventing disease states and conditions and cosmetic conditions mediated through these receptors and related methods thereof in humans and animals.
    Type: Application
    Filed: July 22, 2019
    Publication date: January 23, 2020
    Applicant: Linnaeus Therapeutics, Inc.
    Inventors: Christopher NATALE, Patrick T. MOONEY, Tina GARYANTES, Wayne LUKE